Growing community of inventors

Osaka, Japan

Kai Suzuki

Average Co-Inventor Count = 2.49

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Kai SuzukiMasahiro Hasegawa (5 patents)Kai SuzukiSyed Asfar Mateen (5 patents)Kai SuzukiPraveen Kumar Mididoddi (5 patents)Kai SuzukiShailly Mehrotra (5 patents)Kai SuzukiSusan Elizabeth Shoaf (5 patents)Kai SuzukiSalin Gupta (5 patents)Kai SuzukiTakakuni Matsuda (1 patent)Kai SuzukiToru Nishibayashi (1 patent)Kai SuzukiTadashi Mukai (1 patent)Kai SuzukiMiki Aihara (1 patent)Kai SuzukiHiroyuki Fujiki (1 patent)Kai SuzukiAkitsuna Akagi (1 patent)Kai SuzukiShizuo Kinoshita (1 patent)Kai SuzukiDaiki Kaneko (1 patent)Kai SuzukiKenichi Miyata (1 patent)Kai SuzukiShinsuke Nakagawa (1 patent)Kai SuzukiAtsuya Nakamura (1 patent)Kai SuzukiKoji Ohmoto (1 patent)Kai SuzukiKai Suzuki (11 patents)Masahiro HasegawaMasahiro Hasegawa (9 patents)Syed Asfar MateenSyed Asfar Mateen (5 patents)Praveen Kumar MididoddiPraveen Kumar Mididoddi (5 patents)Shailly MehrotraShailly Mehrotra (5 patents)Susan Elizabeth ShoafSusan Elizabeth Shoaf (5 patents)Salin GuptaSalin Gupta (5 patents)Takakuni MatsudaTakakuni Matsuda (26 patents)Toru NishibayashiToru Nishibayashi (14 patents)Tadashi MukaiTadashi Mukai (11 patents)Miki AiharaMiki Aihara (7 patents)Hiroyuki FujikiHiroyuki Fujiki (6 patents)Akitsuna AkagiAkitsuna Akagi (6 patents)Shizuo KinoshitaShizuo Kinoshita (6 patents)Daiki KanekoDaiki Kaneko (5 patents)Kenichi MiyataKenichi Miyata (4 patents)Shinsuke NakagawaShinsuke Nakagawa (2 patents)Atsuya NakamuraAtsuya Nakamura (2 patents)Koji OhmotoKoji Ohmoto (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Otsuka Pharmaceutical Company, Limited (11 from 845 patents)


11 patents:

1. 12370144 - Centanafadine pharmaceutical formulations, and methods of making and using same

2. 12156941 - Centanafadine pharmaceutical formulations, and methods of making and using same

3. 11980690 - Centanafadine pharmaceutical formulations, and methods of making and using same

4. 11759426 - Centanafadine pharmaceutical formulations, and methods of making and using same

5. 11759470 - Suspension for oral administration comprising amorphous tolvaptan

6. 11564885 - Centanafadine pharmaceutical formulations, and methods of making and using same

7. 10905694 - Pharmaceutical solid preparation comprising benzazepines and production method thereof

8. 9597283 - Injectable depot formulation comprising optically active tolvaptan and process of producing the same

9. 9289389 - Method for producing matrix-type pharmaceutical solid preparation

10. 9173844 - Pharmaceutical solid preparation

11. 9072670 - Matrix-type pharmaceutical solid preparation

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…